Universe Pharmaceuticals' low P/S ratio may indicate market expectations of poor growth or falling revenue, underperforming the industry. With limited growth rates likely to persist, investors are paying less for the stock. If medium-term revenue trends continue, a share price reversal seems unlikely.
$大自然药业(UPC.US)$06:32 AM EDT, 07/19/2022 (MT Newswires) -- Universe Pharmaceuticals (UPC) said Tuesday that it received a notice from the Nasdaq Stock Market that the company is not in compliance with the minimum bid price requirement for continued listing on Nasdaq. The company's share price closed at $0.59 yesterday, in trading that was less than 5% of the average daily volume. The company added that the notification does not currently affect its business operations or its l...
大自然药业股票讨论区
The company's share price closed at $0.59 yesterday, in trading that was less than 5% of the average daily volume.
The company added that the notification does not currently affect its business operations or its l...
暂无评论